{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T10:50:20Z","timestamp":1772794220566,"version":"3.50.1"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100010438","name":"Poznan University Of Medical Sciences","doi-asserted-by":"crossref","award":["Statutory Funding: 502-01-02218346-00292"],"award-info":[{"award-number":["Statutory Funding: 502-01-02218346-00292"]}],"id":[{"id":"10.13039\/501100010438","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod. Sci."],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1177\/1933719118773480","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T03:44:37Z","timestamp":1525923877000},"page":"370-376","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Maternal Serum Endocan Concentration in Pregnancies Complicated by Intrauterine Growth Restriction"],"prefix":"10.1007","volume":"26","author":[{"given":"Agata","family":"Szpera-Gozdziewicz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarzyna","family":"Kosicka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomasz","family":"Gozdziewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariola","family":"Krzyscin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Przemyslaw","family":"Wirstlein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Siemiatkowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franciszek","family":"Glowka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewa","family":"Wender-Ozegowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grzegorz H.","family":"Breborowicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,12,31]]},"reference":[{"issue":"5","key":"26030370_CR1","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00404-017-4341-9","volume":"295","author":"LM Nardozza","year":"2017","unstructured":"Nardozza LM, Caetano, Zamarian AC, et al. Fetal growth restriction: current knowledge. Arch Gynecol Obstet. 2017;295(5):1061\u20131077.","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"26030370_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20060339","volume":"113","author":"T Jansson","year":"2007","unstructured":"Jansson T, Powell TL. Role of the placenta in fetal programming: underlying mechanisms and potential interventional approaches. Clin Sci. 2007;113(1):1\u201313.","journal-title":"Clin Sci"},{"issue":"5\u20136","key":"26030370_CR3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0028-2243(84)90047-9","volume":"18","author":"WB Robertson","year":"1984","unstructured":"Robertson WB, Brosens I, Pijnenborg R, De Wolf F. The making of the placental bed. Eur J Obstet Gynecol Reprod Biol. 1984;18(5\u20136):255\u2013266.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"issue":"2","key":"26030370_CR4","first-page":"110","volume":"1","author":"D Biyashev","year":"2011","unstructured":"Biyashev D, Qin G. E2F and microRNA regulation of angiogenesis. Am J Cardiovasc Dis. 2011;1(2):110\u2013118.","journal-title":"Am J Cardiovasc Dis"},{"issue":"2","key":"26030370_CR5","doi-asserted-by":"crossref","first-page":"279.e1","DOI":"10.1016\/j.ajog.2015.09.068","volume":"214","author":"D Maulik","year":"2016","unstructured":"Maulik D, De A, Ragolia L, et al. Down-regulation of placental neuropilin-1 in fetal growth restriction. Am J Obstet Gynecol. 2016;214(2):279.e1\u2013279.e9.","journal-title":"Am J Obstet Gynecol"},{"issue":"8","key":"26030370_CR6","doi-asserted-by":"crossref","first-page":"19009","DOI":"10.3390\/ijms160819009","volume":"16","author":"I Herraiz","year":"2015","unstructured":"Herraiz I, Sim\u00f3n E, G\u00f3mez-Arriaga P, et al. Angiogenesis-related biomarkers (sflt-1\/plgf) in the prediction and diagnosis of placental dysfunction: an approach for clinical integration. Int J Mol Sci. 2015;16(8):19009\u201319026.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"26030370_CR7","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1084\/jem.20061022","volume":"203","author":"G Girardi","year":"2006","unstructured":"Girardi G, Yarilin D, Thurman JM, Holers VM, Salmon JE. Complement activation induces dysregulation of angiogenic factors and causes fetal rejection and growth restriction. J Exp Med. 2006;203(9):2165\u20132175.","journal-title":"J Exp Med"},{"issue":"10","key":"26030370_CR8","doi-asserted-by":"crossref","first-page":"984","DOI":"10.3109\/14767058.2013.766702","volume":"26","author":"I Szentp\u00e9teri","year":"2013","unstructured":"Szentp\u00e9teri I, Rab A, Kornya L, Kov\u00e1cs P, Jo\u00f3 JG. Gene expression patterns of vascular endothelial growth factor (VEGF-A) in human placenta from pregnancies with intrauterine growth restriction. J Matern Neonatal Med. 2013;26(10):984\u2013989.","journal-title":"J Matern Neonatal Med"},{"issue":"6","key":"26030370_CR9","doi-asserted-by":"crossref","first-page":"579","DOI":"10.4103\/0253-7613.144891","volume":"46","author":"A Kali","year":"2014","unstructured":"Kali A, Shetty KSR. Endocan: a novel circulating proteoglycan. Indian J Pharmacol. 2014;46(6):579.","journal-title":"Indian J Pharmacol"},{"issue":"3","key":"26030370_CR10","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3109\/10520295.2011.577754","volume":"87","author":"S Zhang","year":"2012","unstructured":"Zhang S, Zuo L, Zhou Q, et al. Expression and distribution of endocan in human tissues. Biotech Histochem. 2012;87(3):172\u2013178.","journal-title":"Biotech Histochem"},{"issue":"1","key":"26030370_CR11","first-page":"25","volume":"1765","author":"S Sarrazin","year":"2006","unstructured":"Sarrazin S, Adam E, Lyon M, et al. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta. 2006;1765(1):25\u201337.","journal-title":"Biochim Biophys Acta"},{"issue":"1","key":"26030370_CR12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.atherosclerosis.2015.09.030","volume":"243","author":"S Balta","year":"2015","unstructured":"Balta S, Mikhailidis DP, Demirkol S, Ozturk C, Celik T, Iyisoy A. Endocan: a novel inflammatory indicator in cardiovascular disease? Atherosclerosis. 2015;243(1):339\u2013343.","journal-title":"Atherosclerosis"},{"issue":"6","key":"26030370_CR13","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1182\/blood-2008-05-156331","volume":"112","author":"JW Shin","year":"2008","unstructured":"Shin JW, Huggenberger R, Detmar M. Transcriptional profiling of VEGF-A and VEGF-C target genes in lymphatic endothelium reveals endothelial-specific molecule-1 as a novel mediator of lymphangiogenesis. Blood. 2008;112(6):2318\u20132326.","journal-title":"Blood"},{"issue":"3","key":"26030370_CR14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/j.semperi.2008.02.006","volume":"32","author":"JA Arroyo","year":"2008","unstructured":"Arroyo JA, Winn VD. Vasculogenesis and angiogenesis in the IUGR placenta. Semin Perinatol. 2008;32(3):172\u2013177.","journal-title":"Semin Perinatol"},{"issue":"2","key":"26030370_CR15","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00003081-200606000-00005","volume":"49","author":"D Maulik","year":"2006","unstructured":"Maulik D, Frances Evans J, Ragolia L. Fetal growth restriction: pathogenic mechanisms. Clin Obstet Gynecol. 2006;49(2):219\u2013227.","journal-title":"Clin Obstet Gynecol"},{"issue":"1","key":"26030370_CR16","doi-asserted-by":"crossref","first-page":"e1002220","DOI":"10.1371\/journal.pmed.1002220","volume":"14","author":"T Kiserud","year":"2017","unstructured":"Kiserud T, Piaggio G, Carroli G, et al. The World Health Organization fetal growth charts: a multinational longitudinal study of ultrasound biometric measurements and estimated fetal weight. PLOS Med. 2017;14(1):e1002220.","journal-title":"PLOS Med"},{"issue":"2","key":"26030370_CR17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0020-7292(00)80016-8","volume":"68","author":"ACOG practice bulletin","year":"2000","unstructured":"ACOG practice bulletin. Antepartum fetal surveillance. Number 9, October 1999 (replaces Technical Bulletin Number 188, January 1994). Clinical management guidelines for obstetrician-gynecologists. Int J Gynaecol Obstet. 2000;68(2):175\u2013185.","journal-title":"Int J Gynaecol Obstet"},{"issue":"1","key":"26030370_CR18","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/000331977102200109","volume":"22","author":"RG Gosling","year":"1971","unstructured":"Gosling RG, Dunbar G, King DH, et al. The quantitative analysis of occlusive peripheral arterial disease by a non-intrusive ultrasonic technique. Angiology. 1971;22(1):52\u201355.","journal-title":"Angiology"},{"issue":"5","key":"26030370_CR19","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3109\/14767058.2011.591461","volume":"25","author":"E Soto","year":"2012","unstructured":"Soto E, Romero R, Kusanovic JP, et al. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion. J Matern Fetal Neonatal Med. 2012;25(5):498\u2013507.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"6","key":"26030370_CR20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.placenta.2009.02.009","volume":"30","author":"GJ Burton","year":"2009","unstructured":"Burton GJ, Woods AW, Jauniaux E, Kingdom JCP. Rheological and physiological consequences of conversion of the maternal spiral arteries for uteroplacental blood flow during human pregnancy. Placenta. 2009;30(6):473\u2013482.","journal-title":"Placenta"},{"issue":"8","key":"26030370_CR21","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.placenta.2015.05.016","volume":"36","author":"T Cotechini","year":"2015","unstructured":"Cotechini T, Graham CH. Aberrant maternal inflammation as a cause of pregnancy complications: a potential therapeutic target? Placenta. 2015;36(8):960\u2013966.","journal-title":"Placenta"},{"issue":"6","key":"26030370_CR22","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.167.6.3099","volume":"167","author":"D B\u00e9chard","year":"2001","unstructured":"B\u00e9chard D, Scherpereel A, Hammad H, et al. Human endothelial-cell specific molecule-1 binds directly to the integrin CD11a\/CD18 (LFA-1) and blocks binding to intercellular adhesion molecule-1. J Immunol. 2001;167(6):3099\u20133106.","journal-title":"J Immunol"},{"issue":"2","key":"26030370_CR23","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.jaad.2013.09.013","volume":"70","author":"I Balta","year":"2014","unstructured":"Balta I, Balta S, Koryurek OM, et al. Serum endocan levels as a marker of disease activity in patients with Beh\u00e7et disease. J Am Acad Dermatol. 2014;70(2):291\u2013296.","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"26030370_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.it.2006.06.009","volume":"27","author":"IL Sargent","year":"2006","unstructured":"Sargent IL, Borzychowski AM, Redman CW. NK cells and human pregnancy\u2014an inflammatory view. Trends Immunol. 2006;27(9):399\u2013404.","journal-title":"Trends Immunol"},{"issue":"14","key":"26030370_CR25","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.3109\/14767058.2014.964676","volume":"28","author":"H Adekola","year":"2015","unstructured":"Adekola H, Romero R, Chaemsaithong P, et al. Endocan, a putative endothelial cell marker, is elevated in preeclampsia, decreased in acute pyelonephritis, and unchanged in other obstetrical syndromes. J Matern Fetal Neonatal Med. 2015(14);28:1621\u20131632.","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"2","key":"26030370_CR26","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1097\/01.CCM.0000198525.82124.74","volume":"34","author":"A Scherpereel","year":"2006","unstructured":"Scherpereel A, Depontieu F, Grigoriu B, et al. Endocan, a new endothelial marker in human sepsis. Crit Care Med. 2006;34(2):532\u2013537.","journal-title":"Crit Care Med"},{"key":"26030370_CR27","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1515\/cclm-2013-0638","volume":"52","author":"SJ Kao","year":"2014","unstructured":"Kao SJ, Chuang CY, Tang CH, et al. Plasma endothelial cell-specific molecule-1 (ESM-1) in management of community-acquired pneumonia. Clin Chem Lab Med. 2014;52:445\u2013451.","journal-title":"Clin Chem Lab Med"},{"key":"26030370_CR28","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/MBC.0000000000000071","volume":"25","author":"A G\u00fczel","year":"2014","unstructured":"G\u00fczel A, Duran L, K\u00f6ksal N, et al. Evaluation of serum endothelial cell specific molecule-1 (endocan) levels as a biomarker in patients with pulmonary thromboembolism. Blood Coagul Fibrinolysis 2014;25:272\u2013276.","journal-title":"Blood Coagul Fibrinolysis"},{"key":"26030370_CR29","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1111\/jch.12440","volume":"16","author":"B Afsar","year":"2014","unstructured":"Afsar B, Takir M, Kostek O, Covic A, Kanbay M. Endocan: a new molecule playing a role in the development of hypertension and chronic kidney disease? J Clin Hypertens. 2014;16:914\u2013916.","journal-title":"J Clin Hypertens"},{"key":"26030370_CR30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/j.1471-0528.2008.02057.x","volume":"116","author":"GS Ghosh","year":"2009","unstructured":"Ghosh GS, Gudmundsson S. Uterine and umbilical artery Doppler are comparable in predicting perinatal outcome of growth-restricted fetuses. BJOG. 2009;116:424\u2013430.","journal-title":"BJOG"},{"key":"26030370_CR31","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1067\/mob.2002.127137","volume":"187","author":"P Vergani","year":"2002","unstructured":"Vergani P, Roncaglia N, Andreotti C, et al. Prognostic value of uterine artery Doppler velocimetry in growth-restricted fetuses delivered near term. Am J Obstet Gynecol. 2002;187:932\u2013936.","journal-title":"Am J Obstet Gynecol"},{"key":"26030370_CR32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/uog.15729","volume":"47","author":"A Khalil","year":"2016","unstructured":"Khalil A, Morales-Rosell\u00f3 J, Townsend R, et al. Value of third-trimester cerebroplacental ratio and uterine artery Doppler indices as predictors of stillbirth and perinatal loss. Ultrasound Obstet Gynecol. 2016;47:74\u2013780.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"26030370_CR33","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.bpobgyn.2016.09.003","volume":"38","author":"A Khalil","year":"2017","unstructured":"Khalil A, Thilaganathan B. Role of uteroplacental and fetal Doppler in identifying fetal growth restriction at term. Best Pract Res Clin Obstet Gynaecol. 2017;38:38\u201347.","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"26030370_CR34","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.placenta.2003.10.004","volume":"25","author":"D Charnock-Jones","year":"2004","unstructured":"Charnock-Jones D, Kaufmann P, Mayhew T. Aspects of human fetoplacental vasculogenesis and angiogenesis. I. Molecular regulation. Placenta. 2004;25:103\u2013113.","journal-title":"Placenta"},{"key":"26030370_CR35","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1053\/plac.2002.0865","volume":"23","author":"TM Mayhew","year":"2002","unstructured":"Mayhew TM. Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells. Placenta. 2002;23:742\u2013750.","journal-title":"Placenta"},{"key":"26030370_CR36","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1210\/jc.2014-2385","volume":"100","author":"EJ Su","year":"2015","unstructured":"Su EJ, Xin H, Yin P, et al. Impaired fetoplacental angiogenesis in growth-restricted fetuses with abnormal umbilical artery doppler velocimetry is mediated by Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT). J Clin Endocrinol Metab 2015;100:E30\u2013E40.","journal-title":"J Clin Endocrinol Metab"},{"key":"26030370_CR37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1097\/NEN.0b013e3181a52a7f","volume":"68","author":"CA Maurage","year":"2009","unstructured":"Maurage CA, Adam E, Min\u00e9o JF, et al. Endocan expression and localization in human glioblastomas. J Neuropathol Exp Neurol. 2009;68:633\u2013641.","journal-title":"J Neuropathol Exp Neurol"},{"key":"26030370_CR38","doi-asserted-by":"crossref","first-page":"e13","DOI":"10.4081\/ejh.2011.e13","volume":"55","author":"LM Carrillo","year":"2011","unstructured":"Carrillo LM, Arciniegas E, Rojas H, Ram\u00edrez R. Immunolocalization of endocan during the endothelial-mesenchymal transition process. Eur J Histochem. 2011;55:e13.","journal-title":"Eur J Histochem"},{"key":"26030370_CR39","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1158\/0008-5472.CAN-12-1855","volume":"73","author":"F Roudnicky","year":"2013","unstructured":"Roudnicky F, Poyet C, Wild P, et al. Endocan is upregulated on tumor vessels in invasive bladder cancer where it mediates VEGF-A-induced angiogenesis. Cancer Res. 2013;73:1097\u20131106.","journal-title":"Cancer Res"},{"key":"26030370_CR40","doi-asserted-by":"crossref","first-page":"48341","DOI":"10.1074\/jbc.M108395200","volume":"276","author":"D B\u00e9chard","year":"2001","unstructured":"B\u00e9chard D, Gentina T, Delehedde M, et al. Endocan is a novel chondroitin sulfate\/dermatan sulfate proteoglycan that promotes hepatocyte growth factor\/scatter factor mitogenic activity. J Biol Chem. 2001;276:48341\u201348349.","journal-title":"J Biol Chem"},{"key":"26030370_CR41","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.yexcr.2007.01.021","volume":"313","author":"E Rennel","year":"2007","unstructured":"Rennel E, Mellberg S, Dimberg A, et al. Endocan is a VEGF-A and PI3 K regulated gene with increased expression in human renal cancer. Exp Cell Res. 2007;313:1285\u20131294.","journal-title":"Exp Cell Res"},{"key":"26030370_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/705027","volume":"2013","author":"M Delehedde","year":"2013","unstructured":"Delehedde M, Devenyns L, Maurage CA, Viv\u00e8s RR. Endocan in Cancers: a lesson from a circulating dermatan sulfate proteoglycan. Int J Cell Biol. 2013;2013:1\u201311.","journal-title":"Int J Cell Biol"},{"key":"26030370_CR43","first-page":"6084","volume":"63","author":"A Scherpereel","year":"2003","unstructured":"Scherpereel A, Gentina T, Grigoriu B, et al. Overexpression of endocan induces tumor formation. Cancer Res. 2003;63:6084\u20136089.","journal-title":"Cancer Res"},{"key":"26030370_CR44","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00726-010-0729-6","volume":"40","author":"YH Kang","year":"2011","unstructured":"Kang YH, Ji NY, Lee C II, et al. ESM-1 silencing decreased cell survival, migration, and invasion and modulated cell cycle progression in hepatocellular carcinoma. Amino Acids. 2011;40:1003\u20131013.","journal-title":"Amino Acids"}],"container-title":["Reproductive Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719118773480.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/1933719118773480","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1177\/1933719118773480\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/1933719118773480","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1177\/1933719118773480.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T02:16:43Z","timestamp":1656814603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1177\/1933719118773480"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["26030370"],"URL":"https:\/\/doi.org\/10.1177\/1933719118773480","relation":{},"ISSN":["1933-7191","1933-7205"],"issn-type":[{"value":"1933-7191","type":"print"},{"value":"1933-7205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"31 December 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}